Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain

Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characteriz...

Full description

Saved in:
Bibliographic Details
Published inTranslational psychiatry Vol. 5; no. 8; p. e612
Main Authors Mueller, T M, Remedies, C E, Haroutunian, V, Meador-Woodruff, J H
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 04.08.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1–6, β1–3 or γ2 GABA A R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA A R subunits are abnormally N -glycosylated. N -glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N -glycosylation has on the assembly and trafficking of GABA A Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA A R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia ( N =16) and comparison ( N =14) subjects and found evidence of abnormal localization of the β1 and β2 GABA A R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2 52 kDa ), 50 kDa (β2 50 kDa ) and 48 kDa (β2 48 kDa ). In the ER, we found increased total β2 GABA A R subunit (β2 ALL ) expression driven by increased β2 50 kDa , a decreased ratio of β2 48 kDa :β2 ALL and an increased ratio of β2 50 kDa :β2 48 kDa . Decreased ratios of β1:β2 ALL and β1:β2 50 kDa in both the ER and SYN fractions and an increased ratio of β2 52 kDa :β2 48 kDa at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N -glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA A Rs.
AbstractList Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA(A)R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1-6, β1-3 or γ2 GABA(A)R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA(A)R subunits are abnormally N-glycosylated. N-glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N-glycosylation has on the assembly and trafficking of GABA(A)Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA(A)R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia (N = 16) and comparison (N = 14) subjects and found evidence of abnormal localization of the β1 and β2 GABA(A)R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2(52 kDa)), 50 kDa (β2(50 kDa)) and 48 kDa (β2(48 kDa)). In the ER, we found increased total β2 GABA(A)R subunit (β2(ALL)) expression driven by increased β2(50 kDa), a decreased ratio of β(248 kDa):β2(ALL) and an increased ratio of β2(50 kDa):β2(48 kDa). Decreased ratios of β1:β2(ALL) and β1:β2(50 kDa) in both the ER and SYN fractions and an increased ratio of β2(52 kDa):β(248 kDa) at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N-glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA(A)Rs.Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA(A)R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1-6, β1-3 or γ2 GABA(A)R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA(A)R subunits are abnormally N-glycosylated. N-glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N-glycosylation has on the assembly and trafficking of GABA(A)Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA(A)R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia (N = 16) and comparison (N = 14) subjects and found evidence of abnormal localization of the β1 and β2 GABA(A)R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2(52 kDa)), 50 kDa (β2(50 kDa)) and 48 kDa (β2(48 kDa)). In the ER, we found increased total β2 GABA(A)R subunit (β2(ALL)) expression driven by increased β2(50 kDa), a decreased ratio of β(248 kDa):β2(ALL) and an increased ratio of β2(50 kDa):β2(48 kDa). Decreased ratios of β1:β2(ALL) and β1:β2(50 kDa) in both the ER and SYN fractions and an increased ratio of β2(52 kDa):β(248 kDa) at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N-glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA(A)Rs.
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA(A)R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1-6, β1-3 or γ2 GABA(A)R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA(A)R subunits are abnormally N-glycosylated. N-glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N-glycosylation has on the assembly and trafficking of GABA(A)Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA(A)R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia (N = 16) and comparison (N = 14) subjects and found evidence of abnormal localization of the β1 and β2 GABA(A)R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2(52 kDa)), 50 kDa (β2(50 kDa)) and 48 kDa (β2(48 kDa)). In the ER, we found increased total β2 GABA(A)R subunit (β2(ALL)) expression driven by increased β2(50 kDa), a decreased ratio of β(248 kDa):β2(ALL) and an increased ratio of β2(50 kDa):β2(48 kDa). Decreased ratios of β1:β2(ALL) and β1:β2(50 kDa) in both the ER and SYN fractions and an increased ratio of β2(52 kDa):β(248 kDa) at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N-glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA(A)Rs.
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1–6, β1–3 or γ2 GABA A R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA A R subunits are abnormally N -glycosylated. N -glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N -glycosylation has on the assembly and trafficking of GABA A Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA A R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia ( N =16) and comparison ( N =14) subjects and found evidence of abnormal localization of the β1 and β2 GABA A R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2 52 kDa ), 50 kDa (β2 50 kDa ) and 48 kDa (β2 48 kDa ). In the ER, we found increased total β2 GABA A R subunit (β2 ALL ) expression driven by increased β2 50 kDa , a decreased ratio of β2 48 kDa :β2 ALL and an increased ratio of β2 50 kDa :β2 48 kDa . Decreased ratios of β1:β2 ALL and β1:β2 50 kDa in both the ER and SYN fractions and an increased ratio of β2 52 kDa :β2 48 kDa at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N -glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA A Rs.
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABAA R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1-6, β1-3 or γ2 GABA A R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABAA R subunits are abnormally N-glycosylated. N-glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N-glycosylation has on the assembly and trafficking of GABA A Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABAA R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia (N=16) and comparison (N=14) subjects and found evidence of abnormal localization of the β1 and β2 GABAA R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β252 kDa ), 50 kDa (β250 kDa ) and 48 kDa (β248 kDa ). In the ER, we found increased total β2 GABAA R subunit (β2ALL ) expression driven by increased β250 kDa , a decreased ratio of β248 kDa :β2ALL and an increased ratio of β250 kDa :β248 kDa . Decreased ratios of β1:β2ALL and β1:β250 kDa in both the ER and SYN fractions and an increased ratio of β252 kDa :β248 kDa at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N-glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABAA Rs.
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia, presynaptic GABAergic signaling deficits are among the most replicated findings; however, postsynaptic GABAergic deficits are less well characterized. Our lab has previously demonstrated that although there is no difference in total protein expression of the α1–6, β1–3 or γ2 GABA A R subunits in the superior temporal gyrus (STG) in schizophrenia, the α1, β1 and β2 GABA A R subunits are abnormally N -glycosylated. N -glycosylation is a posttranslational modification that has important functional roles in protein folding, multimer assembly and forward trafficking. To investigate the impact that altered N -glycosylation has on the assembly and trafficking of GABA A Rs in schizophrenia, this study used western blot analysis to measure the expression of α1, α2, β1, β2 and γ2 GABA A R subunits in subcellular fractions enriched for endoplasmic reticulum (ER) and synapses (SYN) from STG of schizophrenia ( N =16) and comparison ( N =14) subjects and found evidence of abnormal localization of the β1 and β2 GABA A R subunits and subunit isoforms in schizophrenia. The β2 subunit is expressed as three isoforms at 52 kDa (β2 52 kDa ), 50 kDa (β2 50 kDa ) and 48 kDa (β2 48 kDa ). In the ER, we found increased total β2 GABA A R subunit (β2 ALL ) expression driven by increased β2 50 kDa , a decreased ratio of β2 48 kDa :β2 ALL and an increased ratio of β2 50 kDa :β2 48 kDa . Decreased ratios of β1:β2 ALL and β1:β2 50 kDa in both the ER and SYN fractions and an increased ratio of β2 52 kDa :β2 48 kDa at the synapse were also identified in schizophrenia. Taken together, these findings provide evidence that alterations of N -glycosylation may contribute to GABAergic signaling deficits in schizophrenia by disrupting the assembly and trafficking of GABA A Rs.
Author Haroutunian, V
Remedies, C E
Mueller, T M
Meador-Woodruff, J H
Author_xml – sequence: 1
  givenname: T M
  surname: Mueller
  fullname: Mueller, T M
  email: toni314@uab.edu
  organization: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham
– sequence: 2
  givenname: C E
  surname: Remedies
  fullname: Remedies, C E
  organization: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Science and Technology Honors Program, University of Alabama at Birmingham
– sequence: 3
  givenname: V
  surname: Haroutunian
  fullname: Haroutunian, V
  organization: Department of Psychiatry, Mount Sinai School of Medicine
– sequence: 4
  givenname: J H
  surname: Meador-Woodruff
  fullname: Meador-Woodruff, J H
  organization: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26241350$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1LJDEQxYO4-DF68i4NXhZ0NJV0JpmL0Iq6C8Ie1HNIp9NOJJO0Sbew89ebcVRmxc0lKfKrx6t6u2jTB28QOgB8CpiKs747JRhYLsgG2iHAxJiCEJtr7220n9ITzoeVAjhsoW0yISVQhnfQXVX7EOfKFWmotXFucCoWLmjl7EL1NvgitMVNdVFVRTTadH2IS3Twtk-F9UXSM7sI3Swab1VRR2X9HvrRKpfM_vs9Qg_XV_eXv8a3f25-X1a3Y00ZJ2M11bppp4aohjXaEKNKKshkkj2KktKWU0Vxq1qMgbS0EZybkgBvKBgOBGo6Qucr3W6o5yZL-D4qJ7to5yr-lUFZ-e-PtzP5GF5kySYlYzwL_HwXiOF5MKmXc5uWS1DehCFJ4JhgwckbevQFfQpD9Hm8TE0BKEDOY4QO1x19WvnYdwaOV4COIaVo2k8EsFwGKvtOLgPNBck0fKG17d9CyeNY95-ek1VPysr-0cQ1o9_gr-aGsVk
CitedBy_id crossref_primary_10_1038_s41386_023_01728_8
crossref_primary_10_1126_sciadv_aau8237
crossref_primary_10_1038_s41398_017_0045_y
crossref_primary_10_1038_s41586_022_04517_3
crossref_primary_10_1038_s41380_020_0761_1
crossref_primary_10_1038_s41398_023_02336_2
crossref_primary_10_1186_s12864_017_3798_z
crossref_primary_10_1016_j_jpsychires_2016_12_019
crossref_primary_10_1016_j_schres_2016_10_024
crossref_primary_10_1038_s41398_019_0610_7
crossref_primary_10_1186_s43141_021_00224_0
crossref_primary_10_3390_genes15040452
crossref_primary_10_3389_fphar_2024_1457811
crossref_primary_10_1016_j_schres_2015_06_002
crossref_primary_10_1038_s41537_020_0093_9
crossref_primary_10_3389_fncel_2018_00273
crossref_primary_10_1007_s12035_024_04477_x
crossref_primary_10_1002_syn_22069
crossref_primary_10_1038_npp_2015_219
crossref_primary_10_1080_15622975_2020_1731925
crossref_primary_10_1016_j_schres_2020_01_025
crossref_primary_10_1093_cercor_bhae044
crossref_primary_10_1016_j_cortex_2016_09_019
crossref_primary_10_1016_j_schres_2018_02_010
crossref_primary_10_1007_s10719_022_10055_x
crossref_primary_10_1007_s00213_017_4705_7
crossref_primary_10_1016_j_bbrc_2017_08_114
crossref_primary_10_1097_WNR_0000000000000880
crossref_primary_10_1016_j_bcp_2016_03_014
crossref_primary_10_1242_jcs_247700
crossref_primary_10_1038_s41398_018_0359_4
crossref_primary_10_3389_fphar_2024_1272534
Cites_doi 10.1038/nrn2370
10.1176/ajp.150.11.1726
10.1016/j.schres.2011.11.029
10.1523/JNEUROSCI.23-15-06315.2003
10.1523/JNEUROSCI.1234-11.2011
10.1038/npp.2013.190
10.3389/fncel.2012.00023
10.1038/336164a0
10.1093/schbul/sbn070
10.1073/pnas.87.24.9966
10.1523/JNEUROSCI.4011-04.2005
10.1016/S0893-133X(01)00225-1
10.1038/sj.mp.4001739
10.1016/j.biopsych.2007.05.027
10.1007/s00702-008-0143-3
10.2183/pjab.88.31
10.1001/archpsyc.57.11.1061
10.1176/appi.ajp.2008.07121845
10.1016/j.neuroscience.2008.11.006
10.1038/mp.2010.47
10.1016/S0165-0173(99)00041-7
10.1152/physrev.00015.2010
10.1016/S0022-3956(99)00039-4
10.1093/oxfordjournals.schbul.a033430
10.1146/annurev.biochem.73.011303.073752
10.1093/cercor/12.10.1063
10.1016/S0166-2236(96)80023-3
10.1074/jbc.271.1.89
10.1371/journal.pone.0009547
10.1016/j.schres.2014.01.028
10.1371/journal.pone.0006977
10.1176/appi.ajp.2007.07081223
10.1016/j.brainres.2006.09.025
10.1042/BST0371415
10.1113/jphysiol.2011.224659
10.1146/annurev.biochem.69.1.69
10.1016/j.neuropharm.2008.07.045
10.1093/glycob/12.4.43R
10.1016/S0006-3223(99)00061-X
10.1093/cercor/bhq169
10.1002/ajmg.b.32116
10.1001/archpsyc.1995.03950160008002
10.1073/pnas.0703806104
10.1093/schbul/15.3.365
10.1038/tp.2013.64
10.1016/j.schres.2009.07.025
10.1111/j.1600-0854.2009.00981.x
10.1124/pr.109.002063
10.1523/JNEUROSCI.2267-05.2005
10.1155/2011/723184
10.1016/j.schres.2005.03.020
10.1111/jnc.12083
10.1007/s00221-005-0290-9
10.1038/2798
10.1016/j.neuropharm.2009.07.027
10.1016/0169-328X(94)00228-7
10.1074/jbc.M112.444372
10.1523/JNEUROSCI.17-17-06587.1997
10.1038/sj.mp.4002011
10.1016/j.jpsychires.2009.12.007
10.1016/j.febslet.2007.04.070
10.1016/S0306-4522(99)00189-X
10.1016/j.neuron.2006.09.020
10.1016/j.schres.2013.01.031
10.1001/archpsyc.55.3.205
10.1097/WNR.0b013e328363bd8a
10.1111/j.1742-4658.2005.04595.x
10.1074/jbc.M110.151449
10.1371/journal.pone.0039190
10.1002/pmic.201000374
10.1074/jbc.M112.360461
10.1038/nrn1648
10.1111/j.1471-4159.2006.04206.x
10.1176/ajp.153.3.321
10.2174/1568026023393507
10.1007/978-0-387-30410-6_11
10.1176/appi.ajp.2008.08030395
10.1093/schbul/sbu111
10.1016/j.tins.2011.10.004
10.1038/npp.2013.84
10.1093/database/bar009
10.1001/archpsyc.57.3.237
10.1523/JNEUROSCI.22-07-02513.2002
10.1385/MN:26:2-3:251
10.1038/sj.mp.4001899
10.1016/S0896-6273(00)00085-4
10.1371/journal.pone.0036351
10.1038/npp.2011.102
10.1016/j.neuropharm.2011.01.022
10.1371/journal.pone.0034586
10.1007/s10059-010-0159-z
10.1016/j.biopsych.2010.09.052
10.1016/S0026-895X(25)13351-8
10.1111/j.2517-6161.1995.tb02031.x
10.1016/S0031-6997(25)06840-1
ContentType Journal Article
Copyright The Author(s) 2015
Copyright Nature Publishing Group Aug 2015
Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2015
– notice: Copyright Nature Publishing Group Aug 2015
– notice: Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/tp.2015.102
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Proquest Health and Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate GABAAR subunit localization in schizophrenia
EISSN 2158-3188
EndPage e612
ExternalDocumentID PMC4564557
4067078261
26241350
10_1038_tp_2015_102
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: MH066392
– fundername: NIMH NIH HHS
  grantid: R01 MH053327
– fundername: NIMH NIH HHS
  grantid: R01 MH064673
– fundername: NIMH NIH HHS
  grantid: P50 MH066392
– fundername: NIMH NIH HHS
  grantid: MH064673
– fundername: NIMH NIH HHS
  grantid: MH53327
GroupedDBID ---
0R~
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAJSJ
AAKDD
ABUWG
ACGFO
ACGFS
ACMJI
ACSMW
ADBBV
ADFRT
AENEX
AFKRA
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
LGEZI
LOTEE
M1P
M~E
NADUK
NAO
NXXTH
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c3572-a9ccdf9e2ad5dce2ea4382668178433f73a30faf0012f3d877e4217d31e7121b3
IEDL.DBID 7X7
ISSN 2158-3188
IngestDate Thu Aug 21 18:23:02 EDT 2025
Mon Jul 21 11:43:51 EDT 2025
Sat Aug 23 13:52:20 EDT 2025
Mon Jul 21 05:38:30 EDT 2025
Thu Jul 03 08:39:08 EDT 2025
Thu Apr 24 23:01:22 EDT 2025
Fri Feb 21 02:38:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3572-a9ccdf9e2ad5dce2ea4382668178433f73a30faf0012f3d877e4217d31e7121b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/1791131110?pq-origsite=%requestingapplication%
PMID 26241350
PQID 1791131110
PQPubID 2041978
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4564557
proquest_miscellaneous_1702087257
proquest_journals_1791131110
pubmed_primary_26241350
crossref_primary_10_1038_tp_2015_102
crossref_citationtrail_10_1038_tp_2015_102
springer_journals_10_1038_tp_2015_102
PublicationCentury 2000
PublicationDate 2015-Aug-04
PublicationDateYYYYMMDD 2015-08-04
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-Aug-04
  day: 04
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
PublicationTitle Translational psychiatry
PublicationTitleAbbrev Transl Psychiatry
PublicationTitleAlternate Transl Psychiatry
PublicationYear 2015
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Benes (CR10) 2000; 31
Green, Kern, Braff, Mintz (CR11) 2000; 26
Hyde, Lipska, Ali, Mathew, Law, Metitiri (CR18) 2011; 31
Helenius, Aebi (CR41) 2004; 73
Chen, Tsang, Zhao, Pun, Yu, Mei (CR81) 2009; 37
Zhao, Xu, Wang, Chen, Ng, Wong (CR75) 2009; 4
Olsen, Sieghart (CR87) 2009; 56
Green (CR12) 1996; 153
Spiro (CR44) 2002; 12
Connolly, Krishek, McDonald, Smart, Moss (CR57) 1996; 271
Lewis, Pierri, Volk, Melchitzky, Woo (CR7) 1999; 46
Cai, Salonikidis, Fei, Schwarz, Schülein, Reutter (CR42) 2005; 272
Pato, Lander, Schulz (CR79) 1989; 15
Beneyto, Abbott, Hashimoto, Lewis (CR28) 2011; 21
Lewis, Cho, Carter (CR59) 2008; 165
Stan, Ghose, Gao, Roberts, Lewis-Amezcua, Hatanpaa (CR69) 2006; 1123
Honea, Meyer-Lindenberg, Hobbs, Pezawas, Mattay, Egan (CR39) 2008; 63
Whiting, McKernan, Iversen (CR27) 1990; 87
Zhao, Xu, Chen, Yu, Tong, Lo (CR82) 2006; 11
Volk, Austin, Pierri, Sampson, Lewis (CR20) 2000; 57
Vithlani, Terunuma, Moss (CR54) 2011; 91
Shan, Mount, Moore, Haroutunian, Meador-Woodruff, McCullumsmith (CR67) 2014; 154
Kang, Heo, Lubec (CR90) 2011; 11
Duncan, Webster, Rothmond, Bahn, Elashoff, Weickert (CR31) 2010; 44
Chen, Xu, Zhang, Liu, Xu, Shen (CR38) 2013; 162B
Sieghart (CR25) 1995; 47
Volk (CR60) 2002; 12
Smiley (CR40) 2009
Benes, Lim, Matzilevich, Walsh, Subburaju, Minns (CR19) 2007; 104
Volk, Lewis (CR8) 2014; 40
Ito, Takeda (CR47) 2012; 88
Alldred, Mulder-Rosi, Lingenfelter, Chen, Lüscher (CR58) 2005; 25
Chen, Olsen (CR95) 2007; 100
Wu, Wang, Beveridge, Tooney, Scott, Carr (CR33) 2012; 7
Bayer, Falkai, Maier (CR84) 1999; 33
Guidotti, Auta, Davis, Gerevini, Dwivedi, Grayson (CR14) 2000; 57
Charych, Liu, Moss, Brandon (CR6) 2009; 57
Hammond, Meador-Woodruff, Haroutunian, McCullumsmith (CR66) 2012; 7
Ohnuma, Augood, Arai, McKenna, Emson (CR30) 1999; 93
Powchik, Davidson, Nemeroff, Haroutunian, Purohit, Losonczy (CR63) 1993; 150
Hashimoto, Volk, Eggan, Mirnics, Pierri, Sun (CR16) 2003; 23
Deng, Huang (CR37) 2006; 168
Jacob, Moss, Jurd (CR53) 2008; 9
Ng, Lo, Pun, Zhao, Yu, Chen (CR80) 2010; 5
Klausberger, Roberts, Somogyi (CR88) 2002; 22
Zhao, Wang, Pun, Mei, Ren, Yu (CR74) 2012; 134
Hashimoto, Arion, Unger, Maldonado-Avilés, Morris, Volk (CR15) 2008; 13
Tretter, Mukherjee, Maric, Schindelin, Sieghart, Moss (CR71) 2012; 6
Tucholski, Simmons, Pinner, McMillan, Haroutunian, Meador-Woodruff (CR50) 2013; 24
Benes, Berretta (CR23) 2001; 25
Uhlhaas, Singer (CR4) 2006; 52
Nakazawa, Zsiros, Jiang, Nakao, Kolata, Zhang (CR5) 2012; 62
Bauer, Haroutunian, McCullumsmith, Meador-Woodruff (CR70) 2009; 116
Magrane (CR77) 2011; 2011
Akbarian, Kim, Potkin, Hagman, Tafazzoli, Bunney (CR13) 1995; 52
Hadingham, Wingrove, Wafford, Bain, Kemp, Palmer (CR89) 1993; 44
Jacob, Bogdanov, Magnus, Saliba, Kittler, Haydon (CR72) 2005; 25
Curley, Lewis (CR9) 2012; 590
Mueller, Haroutunian, Meador-Woodruff (CR36) 2014; 39
Tucholski, Simmons, Pinner, Haroutunian, McCullumsmith, Meador-Woodruff (CR49) 2013; 146
Benjamini, Hochberg (CR73) 1995; 57
Zhou, Huang, Ding, Deel, Arain, Murray (CR85) 2013; 288
Mirnics, Middleton, Marquez, Lewis, Levitt (CR21) 2000; 28
McKinley, Lennon, Carter (CR76) 1995; 28
Petryshen, Middleton, Tahl, Rockwell, Purcell, Aldinger (CR34) 2005; 10
Olivari, Molinari (CR48) 2007; 581
Laha, Tran (CR91) 2013; 124
Lewis, Curley, Glausier, Volk (CR3) 2012; 35
Wu, Wu, Ning, Guo, Ali, MacDonald (CR86) 2012; 287
Sherrington, Brynjolfsson, Petursson, Potter, Dudleston, Barraclough (CR78) 1988; 336
Bauer, Haroutunian, Meador-Woodruff, McCullumsmith (CR51) 2010; 117
McKernan, Whiting (CR26) 1996; 19
Roth, Zuber, Park, Jang, Lee, Kysela (CR45) 2010; 30
Hashimoto, Bazmi, Mirnics, Wu, Sampson, Lewis (CR17) 2008; 165
Lewis, Hashimoto, Volk (CR2) 2005; 6
Lo, Lagrange, Hernandez, Harrison, Dell, Haslam (CR93) 2010; 285
Pun, Zhao, Lo, Ng, Tsang, Nimgaonkar (CR83) 2011; 16
Buchanan, Keefe, Lieberman, Barch, Csernansky, Goff (CR61) 2011; 69
Purohit, Perl, Haroutunian, Powchik, Davidson, Davis (CR65) 1998; 55
Essrich, Lorez, Benson, Fritschy, Lüscher (CR56) 1998; 1
Bullock, Cardon, Bustillo, Roberts, Perrone-Bizzozero (CR35) 2008; 165
Gonzalez-Burgos, Lewis (CR22) 2008; 34
Gonzalez-Burgos, Fish, Lewis (CR1) 2011; 2011
Uusi-Oukari, Korpi (CR92) 2010; 62
Glausier, Lewis (CR29) 2011; 36
Fatemi, Folsom, Rooney, Thuras (CR32) 2013; 3
Kittler, McAinsh, Moss (CR55) 2002; 26
Mulligan, Wang, Adler, Mozhui, Lu, Williams (CR24) 2012; 7
Dennis, Lau, Demetriou, Nabi (CR43) 2009; 10
Katsel, Davis, Gorman, Haroutunian (CR64) 2005; 77
Sieghart, Sperk (CR52) 2002; 2
Goebel-Goody, Davies, Alvestad Linger, Freund, Browning (CR68) 2009; 158
Rubio, Wood, Haroutunian, Meador-Woodruff (CR62) 2013; 38
Parodi (CR46) 2000; 69
Gorrie, Vallis, Stephenson, Whitfield, Browning, Smart (CR94) 1997; 17
DA Lewis (BFtp2015102_CR3) 2012; 35
C Zhao (BFtp2015102_CR74) 2012; 134
WM Bullock (BFtp2015102_CR35) 2008; 165
AJ Parodi (BFtp2015102_CR46) 2000; 69
MF Green (BFtp2015102_CR12) 1996; 153
FM Benes (BFtp2015102_CR23) 2001; 25
P Powchik (BFtp2015102_CR63) 1993; 150
TC Jacob (BFtp2015102_CR72) 2005; 25
SM Goebel-Goody (BFtp2015102_CR68) 2009; 158
J Roth (BFtp2015102_CR45) 2010; 30
KL Hadingham (BFtp2015102_CR89) 1993; 44
R Sherrington (BFtp2015102_CR78) 1988; 336
C Zhou (BFtp2015102_CR85) 2013; 288
T Klausberger (BFtp2015102_CR88) 2002; 22
M Beneyto (BFtp2015102_CR28) 2011; 21
D Shan (BFtp2015102_CR67) 2014; 154
TM Hyde (BFtp2015102_CR18) 2011; 31
M Vithlani (BFtp2015102_CR54) 2011; 91
M Magrane (BFtp2015102_CR77) 2011; 2011
C Zhao (BFtp2015102_CR82) 2006; 11
T Hashimoto (BFtp2015102_CR16) 2003; 23
C Deng (BFtp2015102_CR37) 2006; 168
DE Bauer (BFtp2015102_CR51) 2010; 117
JC Hammond (BFtp2015102_CR66) 2012; 7
FM Benes (BFtp2015102_CR19) 2007; 104
S Akbarian (BFtp2015102_CR13) 1995; 52
J Tucholski (BFtp2015102_CR49) 2013; 146
P Katsel (BFtp2015102_CR64) 2005; 77
G Cai (BFtp2015102_CR42) 2005; 272
JQ Wu (BFtp2015102_CR33) 2012; 7
DA Lewis (BFtp2015102_CR59) 2008; 165
PJ Uhlhaas (BFtp2015102_CR4) 2006; 52
P Whiting (BFtp2015102_CR27) 1990; 87
Y Benjamini (BFtp2015102_CR73) 1995; 57
K Nakazawa (BFtp2015102_CR5) 2012; 62
W Sieghart (BFtp2015102_CR52) 2002; 2
DW Volk (BFtp2015102_CR8) 2014; 40
T Ohnuma (BFtp2015102_CR30) 1999; 93
J Tucholski (BFtp2015102_CR50) 2013; 24
DW Volk (BFtp2015102_CR20) 2000; 57
DP Purohit (BFtp2015102_CR65) 1998; 55
TC Jacob (BFtp2015102_CR53) 2008; 9
GH Gorrie (BFtp2015102_CR94) 1997; 17
JR Glausier (BFtp2015102_CR29) 2011; 36
Y Ito (BFtp2015102_CR47) 2012; 88
D McKinley (BFtp2015102_CR76) 1995; 28
DA Lewis (BFtp2015102_CR2) 2005; 6
TA Bayer (BFtp2015102_CR84) 1999; 33
DA Lewis (BFtp2015102_CR7) 1999; 46
DE Bauer (BFtp2015102_CR70) 2009; 116
CE Duncan (BFtp2015102_CR31) 2010; 44
C Essrich (BFtp2015102_CR56) 1998; 1
V Tretter (BFtp2015102_CR71) 2012; 6
MF Green (BFtp2015102_CR11) 2000; 26
J Chen (BFtp2015102_CR38) 2013; 162B
RW Buchanan (BFtp2015102_CR61) 2011; 69
X Wu (BFtp2015102_CR86) 2012; 287
CN Connolly (BFtp2015102_CR57) 1996; 271
C Zhao (BFtp2015102_CR75) 2009; 4
K Mirnics (BFtp2015102_CR21) 2000; 28
S Olivari (BFtp2015102_CR48) 2007; 581
J Chen (BFtp2015102_CR81) 2009; 37
AR Guidotti (BFtp2015102_CR14) 2000; 57
JT Kittler (BFtp2015102_CR55) 2002; 26
CN Pato (BFtp2015102_CR79) 1989; 15
FW Pun (BFtp2015102_CR83) 2011; 16
RG Spiro (BFtp2015102_CR44) 2002; 12
DW Volk (BFtp2015102_CR60) 2002; 12
T Hashimoto (BFtp2015102_CR15) 2008; 13
RM McKernan (BFtp2015102_CR26) 1996; 19
JF Smiley (BFtp2015102_CR40) 2009
M Uusi-Oukari (BFtp2015102_CR92) 2010; 62
A Helenius (BFtp2015102_CR41) 2004; 73
MD Rubio (BFtp2015102_CR62) 2013; 38
MJ Alldred (BFtp2015102_CR58) 2005; 25
W Sieghart (BFtp2015102_CR25) 1995; 47
TL Petryshen (BFtp2015102_CR34) 2005; 10
RA Honea (BFtp2015102_CR39) 2008; 63
WY Lo (BFtp2015102_CR93) 2010; 285
AA Curley (BFtp2015102_CR9) 2012; 590
FM Benes (BFtp2015102_CR10) 2000; 31
JW Dennis (BFtp2015102_CR43) 2009; 10
G Gonzalez-Burgos (BFtp2015102_CR22) 2008; 34
AD Stan (BFtp2015102_CR69) 2006; 1123
RW Olsen (BFtp2015102_CR87) 2009; 56
KT Laha (BFtp2015102_CR91) 2013; 124
SH Fatemi (BFtp2015102_CR32) 2013; 3
Z-W Chen (BFtp2015102_CR95) 2007; 100
EI Charych (BFtp2015102_CR6) 2009; 57
T Hashimoto (BFtp2015102_CR17) 2008; 165
MK Mulligan (BFtp2015102_CR24) 2012; 7
SU Kang (BFtp2015102_CR90) 2011; 11
G Gonzalez-Burgos (BFtp2015102_CR1) 2011; 2011
S-K Ng (BFtp2015102_CR80) 2010; 5
TM Mueller (BFtp2015102_CR36) 2014; 39
10465426 - Neuroscience. 1999;93(2):441-8
15659595 - J Neurosci. 2005 Jan 19;25(3):594-603
20404824 - Mol Psychiatry. 2011 May;16(5):557-68
21277876 - Neuropharmacology. 2012 Mar;62(3):1574-83
8214183 - Am J Psychiatry. 1993 Nov;150(11):1726-7
8610818 - Am J Psychiatry. 1996 Mar;153(3):321-30
23917429 - Neuropsychopharmacology. 2014 Feb;39(3):528-37
8658597 - Trends Neurosci. 1996 Apr;19(4):139-43
18760291 - Neuropharmacology. 2009 Jan;56(1):141-8
21447597 - Database (Oxford). 2011;2011:bar009
10472415 - Biol Psychiatry. 1999 Sep 1;46(5):616-26
23744069 - J Biol Chem. 2013 Jul 19;288(29):21458-72
18281411 - Am J Psychiatry. 2008 Apr;165(4):479-89
15923110 - Schizophr Res. 2005 Sep 15;77(2-3):241-52
17553960 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9
10711910 - Arch Gen Psychiatry. 2000 Mar;57(3):237-45
20100621 - J Psychiatr Res. 2010 Jul;44(10):673-81
12042244 - Glycobiology. 2002 Apr;12(4):43R-56R
16362364 - Exp Brain Res. 2006 Jan;168(4):587-90
19763268 - PLoS One. 2009;4(9):e6977
24022508 - Transl Psychiatry. 2013;3:e303
10719152 - Brain Res Brain Res Rev. 2000 Mar;31(2-3):251-69
17499246 - FEBS Lett. 2007 Jul 31;581(19):3658-64
1702226 - Proc Natl Acad Sci U S A. 1990 Dec;87(24):9966-70
18923069 - Am J Psychiatry. 2008 Dec;165(12):1594-603
18923067 - Am J Psychiatry. 2008 Dec;165(12):1585-93
21538884 - Proteomics. 2011 Jun;11(11):2171-81
8264558 - Mol Pharmacol. 1993 Dec;44(6):1211-8
10755673 - Schizophr Bull. 2000;26(1):119-36
2683037 - Schizophr Bull. 1989;15(3):365-72
23462048 - Schizophr Res. 2013 May;146(1-3):177-83
19139805 - J Neural Transm (Vienna). 2009 Apr;116(4):487-91
19631671 - Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95
20843900 - Cereb Cortex. 2011 May;21(5):999-1011
23169775 - Am J Med Genet B Neuropsychiatr Genet. 2013 Jan;162B(1):36-43
20123953 - Pharmacol Rev. 2010 Mar;62(1):97-135
21145041 - Biol Psychiatry. 2011 Mar 1;69(5):442-9
11377916 - Neuropsychopharmacology. 2001 Jul;25(1):1-27
18586694 - Schizophr Bull. 2008 Sep;34(5):944-61
16983389 - Mol Psychiatry. 2006 Dec;11(12):1092-105
22558445 - PLoS One. 2012;7(4):e36351
19716271 - Schizophr Res. 2010 Mar;117(1):92-8
22314014 - Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(2):31-40
10628531 - J Psychiatr Res. 1999 Nov-Dec;33(6):543-8
10196563 - Nat Neurosci. 1998 Nov;1(7):563-71
23820740 - Neuroreport. 2013 Aug 21;24(12):688-91
9254671 - J Neurosci. 1997 Sep 1;17(17):6587-96
20221451 - PLoS One. 2010;5(3):e9547
22615685 - Front Cell Neurosci. 2012 May 15;6:23
22711532 - J Biol Chem. 2012 Aug 10;287(33):27417-30
12217970 - Cereb Cortex. 2002 Oct;12(10):1063-70
7707873 - Brain Res Mol Brain Res. 1995 Jan;28(1):175-9
21677653 - Neuropsychopharmacology. 2011 Sep;36(10):2103-10
21904685 - Neural Plast. 2011;2011:723184
11086983 - Neuron. 2000 Oct;28(1):53-67
16172613 - Mol Psychiatry. 2005 Dec;10(12):1074-88, 1057
11074872 - Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
7702443 - Arch Gen Psychiatry. 1995 Apr;52(4):258-66
19041929 - Neuroscience. 2009 Feb 18;158(4):1446-59
15189166 - Annu Rev Biochem. 2004;73:1019-49
15794750 - FEBS J. 2005 Apr;272(7):1625-38
22206711 - Schizophr Res. 2012 Feb;134(2-3):260-6
11923416 - J Neurosci. 2002 Apr 1;22(7):2513-21
22506031 - PLoS One. 2012;7(4):e34586
15803162 - Nat Rev Neurosci. 2005 Apr;6(4):312-24
16280585 - J Neurosci. 2005 Nov 9;25(45):10469-78
19909288 - Biochem Soc Trans. 2009 Dec;37(Pt 6):1415-8
12428759 - Mol Neurobiol. 2002 Oct-Dec;26(2-3):251-68
20639197 - J Biol Chem. 2010 Oct 8;285(41):31348-61
17689500 - Biol Psychiatry. 2008 Mar 1;63(5):465-74
12867516 - J Neurosci. 2003 Jul 16;23(15):6315-26
21795557 - J Neurosci. 2011 Jul 27;31(30):11088-95
12171572 - Curr Top Med Chem. 2002 Aug;2(8):795-816
9510214 - Arch Gen Psychiatry. 1998 Mar;55(3):205-11
23121119 - J Neurochem. 2013 Jan;124(2):200-9
25053651 - Schizophr Bull. 2014 Sep;40(5):952-7
18382465 - Nat Rev Neurosci. 2008 May;9(5):331-43
17045977 - Brain Res. 2006 Dec 6;1123(1):1-11
2903449 - Nature. 1988 Nov 10;336(6195):164-7
22154068 - Trends Neurosci. 2012 Jan;35(1):57-67
22720072 - PLoS One. 2012;7(6):e39190
17015233 - Neuron. 2006 Oct 5;52(1):155-68
17083446 - J Neurochem. 2007 Jan;100(2):279-94
22219337 - J Physiol. 2012 Feb 15;590(4):715-24
21340671 - Mol Cells. 2010 Dec;30(6):497-506
21742794 - Physiol Rev. 2011 Jul;91(3):1009-22
8550630 - J Biol Chem. 1996 Jan 5;271(1):89-96
17471287 - Mol Psychiatry. 2008 Feb;13(2):147-61
7568326 - Pharmacol Rev. 1995 Jun;47(2):181-234
23571678 - Neuropsychopharmacology. 2013 Sep;38(10):1910-20
24560881 - Schizophr Res. 2014 Apr;154(1-3):1-13
19761541 - Traffic. 2009 Nov;10(11):1569-78
10966453 - Annu Rev Biochem. 2000;69:69-93
References_xml – volume: 9
  start-page: 331
  year: 2008
  end-page: 343
  ident: CR53
  article-title: GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn2370
– volume: 150
  start-page: 1726
  year: 1993
  end-page: 1727
  ident: CR63
  article-title: Alzheimer’s-disease-related protein in geriatric schizophrenic patients with cognitive impairment
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.150.11.1726
– volume: 134
  start-page: 260
  year: 2012
  end-page: 266
  ident: CR74
  article-title: Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.11.029
– volume: 23
  start-page: 6315
  year: 2003
  end-page: 6326
  ident: CR16
  article-title: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-15-06315.2003
– volume: 31
  start-page: 11088
  year: 2011
  end-page: 11095
  ident: CR18
  article-title: Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1234-11.2011
– volume: 39
  start-page: 528
  year: 2014
  end-page: 537
  ident: CR36
  article-title: -Glycosylation of GABAA receptor subunits is altered in Schizophrenia
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2013.190
– volume: 6
  start-page: 23
  year: 2012
  ident: CR71
  article-title: Gephyrin, the enigmatic organizer at GABAergic synapses
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2012.00023
– volume: 336
  start-page: 164
  year: 1988
  end-page: 167
  ident: CR78
  article-title: Localization of a susceptibility locus for schizophrenia on chromosome 5
  publication-title: Nature
  doi: 10.1038/336164a0
– volume: 34
  start-page: 944
  year: 2008
  end-page: 961
  ident: CR22
  article-title: GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbn070
– volume: 87
  start-page: 9966
  year: 1990
  end-page: 9970
  ident: CR27
  article-title: Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.87.24.9966
– volume: 44
  start-page: 1211
  year: 1993
  end-page: 1218
  ident: CR89
  article-title: Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors
  publication-title: Mol Pharmacol
– volume: 25
  start-page: 594
  year: 2005
  end-page: 603
  ident: CR58
  article-title: Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4011-04.2005
– volume: 25
  start-page: 1
  year: 2001
  end-page: 27
  ident: CR23
  article-title: GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00225-1
– volume: 10
  start-page: 1074
  year: 2005
  end-page: 1088
  ident: CR34
  article-title: Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001739
– volume: 63
  start-page: 465
  year: 2008
  end-page: 474
  ident: CR39
  article-title: Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.05.027
– volume: 116
  start-page: 487
  year: 2009
  end-page: 491
  ident: CR70
  article-title: Expression of four housekeeping proteins in elderly patients with schizophrenia
  publication-title: J Neural Transm
  doi: 10.1007/s00702-008-0143-3
– volume: 88
  start-page: 31
  year: 2012
  end-page: 40
  ident: CR47
  article-title: Analysis of glycoprotein processing in the endoplasmic reticulum using synthetic oligosaccharides
  publication-title: Proc Jpn Acad Ser B Phys Biol Sci
  doi: 10.2183/pjab.88.31
– volume: 57
  start-page: 1061
  year: 2000
  end-page: 1069
  ident: CR14
  article-title: Decrease in reelin and glutamic acid decarboxylase 67 (GAD 67 ) expression in schizophrenia and bipolar disorder
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.57.11.1061
– volume: 165
  start-page: 1594
  year: 2008
  end-page: 1603
  ident: CR35
  article-title: Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.07121845
– volume: 158
  start-page: 1446
  year: 2009
  end-page: 1459
  ident: CR68
  article-title: Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2008.11.006
– volume: 16
  start-page: 557
  year: 2011
  end-page: 568
  ident: CR83
  article-title: Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor β(2) subunit
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2010.47
– volume: 31
  start-page: 251
  year: 2000
  end-page: 269
  ident: CR10
  article-title: Emerging principles of altered neural circuitry in schizophrenia
  publication-title: Brain Res Rev
  doi: 10.1016/S0165-0173(99)00041-7
– volume: 91
  start-page: 1009
  year: 2011
  end-page: 1022
  ident: CR54
  article-title: The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapses
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00015.2010
– volume: 33
  start-page: 543
  year: 1999
  end-page: 548
  ident: CR84
  article-title: Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the ‘Two hit hypothesis.’
  publication-title: J Psychiatr Res
  doi: 10.1016/S0022-3956(99)00039-4
– volume: 26
  start-page: 119
  year: 2000
  end-page: 136
  ident: CR11
  article-title: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘right stuff’?
  publication-title: Schizophr Bull
  doi: 10.1093/oxfordjournals.schbul.a033430
– volume: 73
  start-page: 1019
  year: 2004
  end-page: 1049
  ident: CR41
  article-title: Roles of -linked glycans in the endoplasmic reticulum
  publication-title: Annu Rev Biochem.
  doi: 10.1146/annurev.biochem.73.011303.073752
– volume: 12
  start-page: 1063
  year: 2002
  end-page: 1070
  ident: CR60
  article-title: Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/12.10.1063
– volume: 19
  start-page: 139
  year: 1996
  end-page: 143
  ident: CR26
  article-title: Which GABAA-receptor subtypes really occur in the brain?
  publication-title: Trends Neurosci
  doi: 10.1016/S0166-2236(96)80023-3
– volume: 271
  start-page: 89
  year: 1996
  end-page: 96
  ident: CR57
  article-title: Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.1.89
– volume: 5
  start-page: e9547
  year: 2010
  ident: CR80
  article-title: A recombination hotspot in a schizophrenia-associated region of GABRB2
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009547
– volume: 154
  start-page: 1
  year: 2014
  end-page: 13
  ident: CR67
  article-title: Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2014.01.028
– volume: 4
  start-page: e6977
  year: 2009
  ident: CR75
  article-title: Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006977
– volume: 165
  start-page: 479
  year: 2008
  end-page: 489
  ident: CR17
  article-title: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2007.07081223
– volume: 1123
  start-page: 1
  year: 2006
  end-page: 11
  ident: CR69
  article-title: Human postmortem tissue: what quality markers matter?
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2006.09.025
– volume: 37
  start-page: 1415
  issue: Pt 6
  year: 2009
  end-page: 1418
  ident: CR81
  article-title: GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST0371415
– volume: 590
  start-page: 715
  issue: Pt 4
  year: 2012
  end-page: 724
  ident: CR9
  article-title: Cortical basket cell dysfunction in schizophrenia
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2011.224659
– volume: 69
  start-page: 69
  year: 2000
  end-page: 93
  ident: CR46
  article-title: Protein glucosylation and its role in protein folding
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.69.1.69
– volume: 56
  start-page: 141
  year: 2009
  end-page: 148
  ident: CR87
  article-title: GABA A receptors: subtypes provide diversity of function and pharmacology
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2008.07.045
– volume: 12
  start-page: 43R
  year: 2002
  end-page: 56R
  ident: CR44
  article-title: Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds
  publication-title: Glycobiology
  doi: 10.1093/glycob/12.4.43R
– volume: 46
  start-page: 616
  year: 1999
  end-page: 626
  ident: CR7
  article-title: Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00061-X
– volume: 21
  start-page: 999
  year: 2011
  end-page: 1011
  ident: CR28
  article-title: Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhq169
– volume: 162B
  start-page: 36
  year: 2013
  end-page: 43
  ident: CR38
  article-title: Comparative study of regional homogeneity in schizophrenia and major depressive disorder
  publication-title: Am J Med Genet B Neuropsychiatr Genet
  doi: 10.1002/ajmg.b.32116
– volume: 52
  start-page: 258
  year: 1995
  end-page: 266
  ident: CR13
  article-title: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1995.03950160008002
– volume: 57
  start-page: 289
  year: 1995
  end-page: 300
  ident: CR73
  article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing
  publication-title: J R Stat Soc
– volume: 104
  start-page: 10164
  year: 2007
  end-page: 10169
  ident: CR19
  article-title: Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0703806104
– volume: 15
  start-page: 365
  year: 1989
  end-page: 372
  ident: CR79
  article-title: Prospects for the genetic analysis of schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/15.3.365
– volume: 3
  start-page: e303
  year: 2013
  ident: CR32
  article-title: Expression of GABAA α2-, β1- and ɛ-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2013.64
– volume: 117
  start-page: 92
  year: 2010
  end-page: 98
  ident: CR51
  article-title: Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.07.025
– volume: 10
  start-page: 1569
  year: 2009
  end-page: 1578
  ident: CR43
  article-title: Adaptive regulation at the cell surface by -glycosylation
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00981.x
– volume: 62
  start-page: 97
  year: 2010
  end-page: 135
  ident: CR92
  article-title: Regulation of GABA(A) receptor subunit expression by pharmacological agents
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.109.002063
– volume: 25
  start-page: 10469
  year: 2005
  end-page: 10478
  ident: CR72
  article-title: Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2267-05.2005
– volume: 2011
  start-page: 723184
  year: 2011
  ident: CR1
  article-title: GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia
  publication-title: Neural Plast
  doi: 10.1155/2011/723184
– volume: 77
  start-page: 241
  year: 2005
  end-page: 252
  ident: CR64
  article-title: Variations in differential gene expression patterns across multiple brain regions in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.03.020
– volume: 124
  start-page: 200
  year: 2013
  end-page: 209
  ident: CR91
  article-title: Multiple tyrosine residues at the GABA binding pocket influence surface expression and mediate kinetics of the GABAA receptor
  publication-title: J Neurochem
  doi: 10.1111/jnc.12083
– volume: 168
  start-page: 587
  year: 2006
  end-page: 590
  ident: CR37
  article-title: Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia
  publication-title: Exp Brain Res
  doi: 10.1007/s00221-005-0290-9
– volume: 1
  start-page: 563
  year: 1998
  end-page: 571
  ident: CR56
  article-title: Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin
  publication-title: Nat Neurosci
  doi: 10.1038/2798
– volume: 57
  start-page: 481
  year: 2009
  end-page: 495
  ident: CR6
  article-title: GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2009.07.027
– volume: 28
  start-page: 175
  year: 1995
  end-page: 179
  ident: CR76
  article-title: Cloning, sequence analysis and expression of two forms of mRNA coding for the human β 2 subunit of the GABA A receptor
  publication-title: Mol Brain Res
  doi: 10.1016/0169-328X(94)00228-7
– volume: 288
  start-page: 21458
  year: 2013
  end-page: 21472
  ident: CR85
  article-title: Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.444372
– volume: 17
  start-page: 6587
  year: 1997
  end-page: 6596
  ident: CR94
  article-title: Assembly of GABAA receptors composed of alpha1 and beta2 subunits in both cultured neurons and fibroblasts
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.17-17-06587.1997
– volume: 13
  start-page: 147
  year: 2008
  end-page: 161
  ident: CR15
  article-title: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4002011
– volume: 44
  start-page: 673
  year: 2010
  end-page: 681
  ident: CR31
  article-title: Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2009.12.007
– volume: 581
  start-page: 3658
  year: 2007
  end-page: 3664
  ident: CR48
  article-title: Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.04.070
– volume: 93
  start-page: 441
  year: 1999
  end-page: 448
  ident: CR30
  article-title: Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(99)00189-X
– volume: 52
  start-page: 155
  year: 2006
  end-page: 168
  ident: CR4
  article-title: Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology
  publication-title: Neuron
  doi: 10.1016/j.neuron.2006.09.020
– volume: 146
  start-page: 177
  year: 2013
  end-page: 183
  ident: CR49
  article-title: Abnormal -linked glycosylation of cortical AMPA receptor subunits in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.01.031
– volume: 55
  start-page: 205
  year: 1998
  end-page: 211
  ident: CR65
  article-title: Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.55.3.205
– volume: 24
  start-page: 688
  year: 2013
  end-page: 691
  ident: CR50
  article-title: -linked glycosylation of cortical -methyl-D-aspartate and kainate receptor subunits in schizophrenia
  publication-title: Neuroreport
  doi: 10.1097/WNR.0b013e328363bd8a
– volume: 272
  start-page: 1625
  year: 2005
  end-page: 1638
  ident: CR42
  article-title: The role of -glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal -glycans facilitate efficient GABA-uptake activity of the GABA transporter
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2005.04595.x
– volume: 285
  start-page: 31348
  year: 2010
  end-page: 31361
  ident: CR93
  article-title: Glycosylation of β2 subunits regulates GABAA receptor biogenesis and channel gating
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.151449
– volume: 7
  start-page: e39190
  year: 2012
  ident: CR66
  article-title: AMPA receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039190
– volume: 11
  start-page: 2171
  year: 2011
  end-page: 2181
  ident: CR90
  article-title: Mass spectrometric analysis of GABAA receptor subtypes and phosphorylations from mouse hippocampus
  publication-title: Proteomics
  doi: 10.1002/pmic.201000374
– volume: 287
  start-page: 27417
  year: 2012
  end-page: 27430
  ident: CR86
  article-title: γ-Aminobutyric acid type A (GABAA) receptor α subunits play a direct role in synaptic versus extrasynaptic targeting
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.360461
– volume: 6
  start-page: 312
  year: 2005
  end-page: 324
  ident: CR2
  article-title: Cortical inhibitory neurons and schizophrenia
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1648
– volume: 100
  start-page: 279
  year: 2007
  end-page: 294
  ident: CR95
  article-title: GABAA receptor associated proteins: a key factor regulating GABAA receptor function
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.04206.x
– volume: 153
  start-page: 321
  year: 1996
  end-page: 330
  ident: CR12
  article-title: What are the functional consequences of neurocognitive deficits in schizophrenia?
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.153.3.321
– volume: 2
  start-page: 795
  year: 2002
  end-page: 816
  ident: CR52
  article-title: Subunit composition, distribution and function of GABA(A) receptor subtypes
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026023393507
– start-page: 353
  year: 2009
  end-page: 381
  ident: CR40
  article-title: Auditory cortex anatomy and asymmetry in schizophrenia
  publication-title: Handbook of Neurochemistry and Molecular Neurobiology
  doi: 10.1007/978-0-387-30410-6_11
– volume: 47
  start-page: 181
  year: 1995
  end-page: 234
  ident: CR25
  article-title: Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes
  publication-title: Pharmacol Rev
– volume: 165
  start-page: 1585
  year: 2008
  end-page: 1593
  ident: CR59
  article-title: Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.08030395
– volume: 40
  start-page: 952
  year: 2014
  end-page: 957
  ident: CR8
  article-title: Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbu111
– volume: 35
  start-page: 57
  year: 2012
  end-page: 67
  ident: CR3
  article-title: Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2011.10.004
– volume: 38
  start-page: 1910
  year: 2013
  end-page: 1920
  ident: CR62
  article-title: Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2013.84
– volume: 2011
  start-page: bar009
  year: 2011
  ident: CR77
  article-title: UniProt Knowledgebase: a hub of integrated protein data
  publication-title: Database (Oxford)
  doi: 10.1093/database/bar009
– volume: 57
  start-page: 237
  year: 2000
  end-page: 245
  ident: CR20
  article-title: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.57.3.237
– volume: 22
  start-page: 2513
  year: 2002
  end-page: 2521
  ident: CR88
  article-title: Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-07-02513.2002
– volume: 26
  start-page: 251
  year: 2002
  end-page: 268
  ident: CR55
  article-title: Mechanisms of GABAA receptor assembly and trafficking
  publication-title: Mol Neurobiol
  doi: 10.1385/MN:26:2-3:251
– volume: 11
  start-page: 1092
  year: 2006
  end-page: 1105
  ident: CR82
  article-title: Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001899
– volume: 28
  start-page: 53
  year: 2000
  end-page: 67
  ident: CR21
  article-title: Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)00085-4
– volume: 7
  start-page: e36351
  year: 2012
  ident: CR33
  article-title: Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036351
– volume: 36
  start-page: 2103
  year: 2011
  end-page: 2110
  ident: CR29
  article-title: Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.102
– volume: 62
  start-page: 1574
  year: 2012
  end-page: 1583
  ident: CR5
  article-title: GABAergic interneuron origin of schizophrenia pathophysiology
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.01.022
– volume: 7
  start-page: e34586
  year: 2012
  ident: CR24
  article-title: Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0034586
– volume: 30
  start-page: 497
  year: 2010
  end-page: 506
  ident: CR45
  article-title: Protein -glycosylation, protein folding, and protein quality control
  publication-title: Mol Cells
  doi: 10.1007/s10059-010-0159-z
– volume: 69
  start-page: 442
  year: 2011
  end-page: 449
  ident: CR61
  article-title: A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.09.052
– volume: 30
  start-page: 497
  year: 2010
  ident: BFtp2015102_CR45
  publication-title: Mol Cells
  doi: 10.1007/s10059-010-0159-z
– volume: 7
  start-page: e39190
  year: 2012
  ident: BFtp2015102_CR66
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039190
– volume: 2011
  start-page: 723184
  year: 2011
  ident: BFtp2015102_CR1
  publication-title: Neural Plast
  doi: 10.1155/2011/723184
– volume: 44
  start-page: 673
  year: 2010
  ident: BFtp2015102_CR31
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2009.12.007
– volume: 3
  start-page: e303
  year: 2013
  ident: BFtp2015102_CR32
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2013.64
– volume: 10
  start-page: 1569
  year: 2009
  ident: BFtp2015102_CR43
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00981.x
– volume: 134
  start-page: 260
  year: 2012
  ident: BFtp2015102_CR74
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.11.029
– volume: 271
  start-page: 89
  year: 1996
  ident: BFtp2015102_CR57
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.1.89
– volume: 46
  start-page: 616
  year: 1999
  ident: BFtp2015102_CR7
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00061-X
– volume: 93
  start-page: 441
  year: 1999
  ident: BFtp2015102_CR30
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(99)00189-X
– volume: 165
  start-page: 479
  year: 2008
  ident: BFtp2015102_CR17
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2007.07081223
– start-page: 353
  volume-title: Handbook of Neurochemistry and Molecular Neurobiology
  year: 2009
  ident: BFtp2015102_CR40
  doi: 10.1007/978-0-387-30410-6_11
– volume: 57
  start-page: 1061
  year: 2000
  ident: BFtp2015102_CR14
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.57.11.1061
– volume: 285
  start-page: 31348
  year: 2010
  ident: BFtp2015102_CR93
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.151449
– volume: 158
  start-page: 1446
  year: 2009
  ident: BFtp2015102_CR68
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2008.11.006
– volume: 57
  start-page: 481
  year: 2009
  ident: BFtp2015102_CR6
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2009.07.027
– volume: 87
  start-page: 9966
  year: 1990
  ident: BFtp2015102_CR27
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.87.24.9966
– volume: 7
  start-page: e34586
  year: 2012
  ident: BFtp2015102_CR24
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0034586
– volume: 150
  start-page: 1726
  year: 1993
  ident: BFtp2015102_CR63
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.150.11.1726
– volume: 31
  start-page: 11088
  year: 2011
  ident: BFtp2015102_CR18
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1234-11.2011
– volume: 44
  start-page: 1211
  year: 1993
  ident: BFtp2015102_CR89
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(25)13351-8
– volume: 165
  start-page: 1594
  year: 2008
  ident: BFtp2015102_CR35
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.07121845
– volume: 38
  start-page: 1910
  year: 2013
  ident: BFtp2015102_CR62
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2013.84
– volume: 34
  start-page: 944
  year: 2008
  ident: BFtp2015102_CR22
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbn070
– volume: 4
  start-page: e6977
  year: 2009
  ident: BFtp2015102_CR75
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0006977
– volume: 63
  start-page: 465
  year: 2008
  ident: BFtp2015102_CR39
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.05.027
– volume: 28
  start-page: 175
  year: 1995
  ident: BFtp2015102_CR76
  publication-title: Mol Brain Res
  doi: 10.1016/0169-328X(94)00228-7
– volume: 5
  start-page: e9547
  year: 2010
  ident: BFtp2015102_CR80
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009547
– volume: 581
  start-page: 3658
  year: 2007
  ident: BFtp2015102_CR48
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.04.070
– volume: 6
  start-page: 23
  year: 2012
  ident: BFtp2015102_CR71
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2012.00023
– volume: 116
  start-page: 487
  year: 2009
  ident: BFtp2015102_CR70
  publication-title: J Neural Transm
  doi: 10.1007/s00702-008-0143-3
– volume: 37
  start-page: 1415
  issue: Pt 6
  year: 2009
  ident: BFtp2015102_CR81
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST0371415
– volume: 162B
  start-page: 36
  year: 2013
  ident: BFtp2015102_CR38
  publication-title: Am J Med Genet B Neuropsychiatr Genet
  doi: 10.1002/ajmg.b.32116
– volume: 590
  start-page: 715
  issue: Pt 4
  year: 2012
  ident: BFtp2015102_CR9
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2011.224659
– volume: 11
  start-page: 2171
  year: 2011
  ident: BFtp2015102_CR90
  publication-title: Proteomics
  doi: 10.1002/pmic.201000374
– volume: 336
  start-page: 164
  year: 1988
  ident: BFtp2015102_CR78
  publication-title: Nature
  doi: 10.1038/336164a0
– volume: 22
  start-page: 2513
  year: 2002
  ident: BFtp2015102_CR88
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-07-02513.2002
– volume: 52
  start-page: 258
  year: 1995
  ident: BFtp2015102_CR13
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1995.03950160008002
– volume: 168
  start-page: 587
  year: 2006
  ident: BFtp2015102_CR37
  publication-title: Exp Brain Res
  doi: 10.1007/s00221-005-0290-9
– volume: 146
  start-page: 177
  year: 2013
  ident: BFtp2015102_CR49
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.01.031
– volume: 91
  start-page: 1009
  year: 2011
  ident: BFtp2015102_CR54
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00015.2010
– volume: 26
  start-page: 251
  year: 2002
  ident: BFtp2015102_CR55
  publication-title: Mol Neurobiol
  doi: 10.1385/MN:26:2-3:251
– volume: 62
  start-page: 97
  year: 2010
  ident: BFtp2015102_CR92
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.109.002063
– volume: 10
  start-page: 1074
  year: 2005
  ident: BFtp2015102_CR34
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001739
– volume: 104
  start-page: 10164
  year: 2007
  ident: BFtp2015102_CR19
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0703806104
– volume: 13
  start-page: 147
  year: 2008
  ident: BFtp2015102_CR15
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4002011
– volume: 288
  start-page: 21458
  year: 2013
  ident: BFtp2015102_CR85
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.444372
– volume: 287
  start-page: 27417
  year: 2012
  ident: BFtp2015102_CR86
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.360461
– volume: 11
  start-page: 1092
  year: 2006
  ident: BFtp2015102_CR82
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001899
– volume: 69
  start-page: 442
  year: 2011
  ident: BFtp2015102_CR61
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.09.052
– volume: 25
  start-page: 10469
  year: 2005
  ident: BFtp2015102_CR72
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2267-05.2005
– volume: 272
  start-page: 1625
  year: 2005
  ident: BFtp2015102_CR42
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2005.04595.x
– volume: 25
  start-page: 594
  year: 2005
  ident: BFtp2015102_CR58
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4011-04.2005
– volume: 15
  start-page: 365
  year: 1989
  ident: BFtp2015102_CR79
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/15.3.365
– volume: 12
  start-page: 43R
  year: 2002
  ident: BFtp2015102_CR44
  publication-title: Glycobiology
  doi: 10.1093/glycob/12.4.43R
– volume: 57
  start-page: 289
  year: 1995
  ident: BFtp2015102_CR73
  publication-title: J R Stat Soc
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 88
  start-page: 31
  year: 2012
  ident: BFtp2015102_CR47
  publication-title: Proc Jpn Acad Ser B Phys Biol Sci
  doi: 10.2183/pjab.88.31
– volume: 17
  start-page: 6587
  year: 1997
  ident: BFtp2015102_CR94
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.17-17-06587.1997
– volume: 9
  start-page: 331
  year: 2008
  ident: BFtp2015102_CR53
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn2370
– volume: 36
  start-page: 2103
  year: 2011
  ident: BFtp2015102_CR29
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.102
– volume: 35
  start-page: 57
  year: 2012
  ident: BFtp2015102_CR3
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2011.10.004
– volume: 26
  start-page: 119
  year: 2000
  ident: BFtp2015102_CR11
  publication-title: Schizophr Bull
  doi: 10.1093/oxfordjournals.schbul.a033430
– volume: 31
  start-page: 251
  year: 2000
  ident: BFtp2015102_CR10
  publication-title: Brain Res Rev
  doi: 10.1016/S0165-0173(99)00041-7
– volume: 165
  start-page: 1585
  year: 2008
  ident: BFtp2015102_CR59
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.08030395
– volume: 62
  start-page: 1574
  year: 2012
  ident: BFtp2015102_CR5
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.01.022
– volume: 16
  start-page: 557
  year: 2011
  ident: BFtp2015102_CR83
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2010.47
– volume: 2011
  start-page: bar009
  year: 2011
  ident: BFtp2015102_CR77
  publication-title: Database (Oxford)
  doi: 10.1093/database/bar009
– volume: 12
  start-page: 1063
  year: 2002
  ident: BFtp2015102_CR60
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/12.10.1063
– volume: 23
  start-page: 6315
  year: 2003
  ident: BFtp2015102_CR16
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-15-06315.2003
– volume: 21
  start-page: 999
  year: 2011
  ident: BFtp2015102_CR28
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhq169
– volume: 124
  start-page: 200
  year: 2013
  ident: BFtp2015102_CR91
  publication-title: J Neurochem
  doi: 10.1111/jnc.12083
– volume: 154
  start-page: 1
  year: 2014
  ident: BFtp2015102_CR67
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2014.01.028
– volume: 33
  start-page: 543
  year: 1999
  ident: BFtp2015102_CR84
  publication-title: J Psychiatr Res
  doi: 10.1016/S0022-3956(99)00039-4
– volume: 69
  start-page: 69
  year: 2000
  ident: BFtp2015102_CR46
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.69.1.69
– volume: 6
  start-page: 312
  year: 2005
  ident: BFtp2015102_CR2
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1648
– volume: 73
  start-page: 1019
  year: 2004
  ident: BFtp2015102_CR41
  publication-title: Annu Rev Biochem.
  doi: 10.1146/annurev.biochem.73.011303.073752
– volume: 1123
  start-page: 1
  year: 2006
  ident: BFtp2015102_CR69
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2006.09.025
– volume: 28
  start-page: 53
  year: 2000
  ident: BFtp2015102_CR21
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)00085-4
– volume: 1
  start-page: 563
  year: 1998
  ident: BFtp2015102_CR56
  publication-title: Nat Neurosci
  doi: 10.1038/2798
– volume: 25
  start-page: 1
  year: 2001
  ident: BFtp2015102_CR23
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00225-1
– volume: 39
  start-page: 528
  year: 2014
  ident: BFtp2015102_CR36
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2013.190
– volume: 24
  start-page: 688
  year: 2013
  ident: BFtp2015102_CR50
  publication-title: Neuroreport
  doi: 10.1097/WNR.0b013e328363bd8a
– volume: 77
  start-page: 241
  year: 2005
  ident: BFtp2015102_CR64
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.03.020
– volume: 47
  start-page: 181
  year: 1995
  ident: BFtp2015102_CR25
  publication-title: Pharmacol Rev
  doi: 10.1016/S0031-6997(25)06840-1
– volume: 7
  start-page: e36351
  year: 2012
  ident: BFtp2015102_CR33
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036351
– volume: 2
  start-page: 795
  year: 2002
  ident: BFtp2015102_CR52
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026023393507
– volume: 117
  start-page: 92
  year: 2010
  ident: BFtp2015102_CR51
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.07.025
– volume: 57
  start-page: 237
  year: 2000
  ident: BFtp2015102_CR20
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.57.3.237
– volume: 56
  start-page: 141
  year: 2009
  ident: BFtp2015102_CR87
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2008.07.045
– volume: 52
  start-page: 155
  year: 2006
  ident: BFtp2015102_CR4
  publication-title: Neuron
  doi: 10.1016/j.neuron.2006.09.020
– volume: 55
  start-page: 205
  year: 1998
  ident: BFtp2015102_CR65
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.55.3.205
– volume: 19
  start-page: 139
  year: 1996
  ident: BFtp2015102_CR26
  publication-title: Trends Neurosci
  doi: 10.1016/S0166-2236(96)80023-3
– volume: 100
  start-page: 279
  year: 2007
  ident: BFtp2015102_CR95
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.04206.x
– volume: 40
  start-page: 952
  year: 2014
  ident: BFtp2015102_CR8
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbu111
– volume: 153
  start-page: 321
  year: 1996
  ident: BFtp2015102_CR12
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.153.3.321
– reference: 21742794 - Physiol Rev. 2011 Jul;91(3):1009-22
– reference: 20221451 - PLoS One. 2010;5(3):e9547
– reference: 17689500 - Biol Psychiatry. 2008 Mar 1;63(5):465-74
– reference: 17471287 - Mol Psychiatry. 2008 Feb;13(2):147-61
– reference: 8550630 - J Biol Chem. 1996 Jan 5;271(1):89-96
– reference: 2903449 - Nature. 1988 Nov 10;336(6195):164-7
– reference: 22615685 - Front Cell Neurosci. 2012 May 15;6:23
– reference: 20100621 - J Psychiatr Res. 2010 Jul;44(10):673-81
– reference: 20123953 - Pharmacol Rev. 2010 Mar;62(1):97-135
– reference: 10628531 - J Psychiatr Res. 1999 Nov-Dec;33(6):543-8
– reference: 10472415 - Biol Psychiatry. 1999 Sep 1;46(5):616-26
– reference: 12428759 - Mol Neurobiol. 2002 Oct-Dec;26(2-3):251-68
– reference: 19716271 - Schizophr Res. 2010 Mar;117(1):92-8
– reference: 17015233 - Neuron. 2006 Oct 5;52(1):155-68
– reference: 23744069 - J Biol Chem. 2013 Jul 19;288(29):21458-72
– reference: 22154068 - Trends Neurosci. 2012 Jan;35(1):57-67
– reference: 16280585 - J Neurosci. 2005 Nov 9;25(45):10469-78
– reference: 15803162 - Nat Rev Neurosci. 2005 Apr;6(4):312-24
– reference: 21447597 - Database (Oxford). 2011;2011:bar009
– reference: 19139805 - J Neural Transm (Vienna). 2009 Apr;116(4):487-91
– reference: 7707873 - Brain Res Mol Brain Res. 1995 Jan;28(1):175-9
– reference: 23121119 - J Neurochem. 2013 Jan;124(2):200-9
– reference: 21340671 - Mol Cells. 2010 Dec;30(6):497-506
– reference: 22314014 - Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(2):31-40
– reference: 2683037 - Schizophr Bull. 1989;15(3):365-72
– reference: 22506031 - PLoS One. 2012;7(4):e34586
– reference: 11086983 - Neuron. 2000 Oct;28(1):53-67
– reference: 18382465 - Nat Rev Neurosci. 2008 May;9(5):331-43
– reference: 19041929 - Neuroscience. 2009 Feb 18;158(4):1446-59
– reference: 9510214 - Arch Gen Psychiatry. 1998 Mar;55(3):205-11
– reference: 15923110 - Schizophr Res. 2005 Sep 15;77(2-3):241-52
– reference: 22206711 - Schizophr Res. 2012 Feb;134(2-3):260-6
– reference: 8214183 - Am J Psychiatry. 1993 Nov;150(11):1726-7
– reference: 23462048 - Schizophr Res. 2013 May;146(1-3):177-83
– reference: 10465426 - Neuroscience. 1999;93(2):441-8
– reference: 9254671 - J Neurosci. 1997 Sep 1;17(17):6587-96
– reference: 17083446 - J Neurochem. 2007 Jan;100(2):279-94
– reference: 21795557 - J Neurosci. 2011 Jul 27;31(30):11088-95
– reference: 18923069 - Am J Psychiatry. 2008 Dec;165(12):1594-603
– reference: 21677653 - Neuropsychopharmacology. 2011 Sep;36(10):2103-10
– reference: 16172613 - Mol Psychiatry. 2005 Dec;10(12):1074-88, 1057
– reference: 15659595 - J Neurosci. 2005 Jan 19;25(3):594-603
– reference: 20639197 - J Biol Chem. 2010 Oct 8;285(41):31348-61
– reference: 17045977 - Brain Res. 2006 Dec 6;1123(1):1-11
– reference: 12217970 - Cereb Cortex. 2002 Oct;12(10):1063-70
– reference: 8658597 - Trends Neurosci. 1996 Apr;19(4):139-43
– reference: 17553960 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9
– reference: 18760291 - Neuropharmacology. 2009 Jan;56(1):141-8
– reference: 22558445 - PLoS One. 2012;7(4):e36351
– reference: 19763268 - PLoS One. 2009;4(9):e6977
– reference: 23917429 - Neuropsychopharmacology. 2014 Feb;39(3):528-37
– reference: 15189166 - Annu Rev Biochem. 2004;73:1019-49
– reference: 10755673 - Schizophr Bull. 2000;26(1):119-36
– reference: 11377916 - Neuropsychopharmacology. 2001 Jul;25(1):1-27
– reference: 1702226 - Proc Natl Acad Sci U S A. 1990 Dec;87(24):9966-70
– reference: 24560881 - Schizophr Res. 2014 Apr;154(1-3):1-13
– reference: 21277876 - Neuropharmacology. 2012 Mar;62(3):1574-83
– reference: 21538884 - Proteomics. 2011 Jun;11(11):2171-81
– reference: 11074872 - Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
– reference: 7702443 - Arch Gen Psychiatry. 1995 Apr;52(4):258-66
– reference: 24022508 - Transl Psychiatry. 2013;3:e303
– reference: 10196563 - Nat Neurosci. 1998 Nov;1(7):563-71
– reference: 22219337 - J Physiol. 2012 Feb 15;590(4):715-24
– reference: 16362364 - Exp Brain Res. 2006 Jan;168(4):587-90
– reference: 11923416 - J Neurosci. 2002 Apr 1;22(7):2513-21
– reference: 19631671 - Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95
– reference: 15794750 - FEBS J. 2005 Apr;272(7):1625-38
– reference: 12867516 - J Neurosci. 2003 Jul 16;23(15):6315-26
– reference: 12171572 - Curr Top Med Chem. 2002 Aug;2(8):795-816
– reference: 17499246 - FEBS Lett. 2007 Jul 31;581(19):3658-64
– reference: 25053651 - Schizophr Bull. 2014 Sep;40(5):952-7
– reference: 23571678 - Neuropsychopharmacology. 2013 Sep;38(10):1910-20
– reference: 10711910 - Arch Gen Psychiatry. 2000 Mar;57(3):237-45
– reference: 19761541 - Traffic. 2009 Nov;10(11):1569-78
– reference: 18586694 - Schizophr Bull. 2008 Sep;34(5):944-61
– reference: 10966453 - Annu Rev Biochem. 2000;69:69-93
– reference: 16983389 - Mol Psychiatry. 2006 Dec;11(12):1092-105
– reference: 8610818 - Am J Psychiatry. 1996 Mar;153(3):321-30
– reference: 18281411 - Am J Psychiatry. 2008 Apr;165(4):479-89
– reference: 12042244 - Glycobiology. 2002 Apr;12(4):43R-56R
– reference: 22720072 - PLoS One. 2012;7(6):e39190
– reference: 23820740 - Neuroreport. 2013 Aug 21;24(12):688-91
– reference: 21904685 - Neural Plast. 2011;2011:723184
– reference: 10719152 - Brain Res Brain Res Rev. 2000 Mar;31(2-3):251-69
– reference: 20404824 - Mol Psychiatry. 2011 May;16(5):557-68
– reference: 22711532 - J Biol Chem. 2012 Aug 10;287(33):27417-30
– reference: 19909288 - Biochem Soc Trans. 2009 Dec;37(Pt 6):1415-8
– reference: 20843900 - Cereb Cortex. 2011 May;21(5):999-1011
– reference: 21145041 - Biol Psychiatry. 2011 Mar 1;69(5):442-9
– reference: 7568326 - Pharmacol Rev. 1995 Jun;47(2):181-234
– reference: 18923067 - Am J Psychiatry. 2008 Dec;165(12):1585-93
– reference: 23169775 - Am J Med Genet B Neuropsychiatr Genet. 2013 Jan;162B(1):36-43
– reference: 8264558 - Mol Pharmacol. 1993 Dec;44(6):1211-8
SSID ssj0000548171
Score 2.0284023
Snippet Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia,...
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA A R). In schizophrenia,...
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABA(A)R). In schizophrenia,...
Inhibitory neurotransmission is primarily mediated by γ-aminobutyric acid (GABA) activating synaptic GABA type A receptors (GABAA R). In schizophrenia,...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e612
SubjectTerms 101/28
631/378/340
692/699/476/1799
82
82/29
82/80
Aged
Behavioral Sciences
Biological Psychology
Blotting, Western
Brain - metabolism
Brain - physiopathology
Case-Control Studies
Endoplasmic Reticulum - chemistry
Female
Glycosylation
Humans
Male
Medicine
Medicine & Public Health
Neurosciences
Original
original-article
Pharmacotherapy
Psychiatry
Receptors, GABA-A - analysis
Receptors, GABA-A - metabolism
Receptors, GABA-A - physiology
Receptors, GABA-B - metabolism
Receptors, GABA-B - physiology
Schizophrenia - metabolism
Schizophrenia - physiopathology
Subcellular Fractions - chemistry
Synapses - chemistry
Temporal Lobe - chemistry
SummonAdditionalLinks – databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA-6gfgifludEmG-CMWlSdv0sYpzDObLHOytJGmCA-mG3f5_c21WNueDby25tMddkrvkLr9DqJvzXqCNYL4OpfIZj4wviWS-EtYeRTw03MDd4dF7NJiw4TScOpzt0qVV1pCW1TK9zg57WgK2JAkBaWAftQGj3Q7qdpoOx8PmSMV6H5zExN3C61G-2Wvb7uw4k7s5kb8Co5W96R-jI-co4rRm7QTt6eIUHYxcKPwMjVNZgL_5hcuVhON3yCfFlWlyVyvx3OC39DlNsV3V9MJuroF0ZedwiWcFLjfT7bCEUhHnaNJ__XgZ-K5Cgq9oGAe-SJTKTaIDkYeW80ALiOtFkRUDZ5SamAraM8KAU2NozuNYM7sHySnRMQmIpBeoVcwLfYWwUtRO3ySRVnlMhlRoIhIOaDZMaW60hx7X8suUgw-HKhZfWRXGpjxbLjIQtn0JPNRtiBc1asbfZJ21IjI3dcoM8FIBA4j0PHTfNNtBD6IUhZ6vgAZqi8Z2ufHQZa235j9BBKHC0PaOtzTaEACg9nZLMfusgLUraB345sNa9xts7bJ__U-6G3QIj1XaIOug1vJ7pW-tK7OUd24I_wBTr_PX
  priority: 102
  providerName: Springer Nature
Title Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain
URI https://link.springer.com/article/10.1038/tp.2015.102
https://www.ncbi.nlm.nih.gov/pubmed/26241350
https://www.proquest.com/docview/1791131110
https://www.proquest.com/docview/1702087257
https://pubmed.ncbi.nlm.nih.gov/PMC4564557
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2FsZexr6XrQsadC8D08iSLflpuKFdCbSMdYW8GUmWWKE42Zz8_7tTFK9Zxp6MrbMtdLrT6e70O4DjVk9yH4zMfGFdJnUZMsutzJzB9ajURdCBzg5fXpUXN3I2L-bJ4dantMqtToyKul048pGfEIwmQcPwyeflz4yqRlF0NZXQeAiHBF1Gs1rN1eBjQXNEc8XTsbyJ0CcrgqjkBQEW7C5Ee9blfpLkX5HSuACdP4UnyXJk9YbVz-CB757Do8sUG38B17XtyAC9Y_3akj-eEkxZXKvSWUu2COxLfVrXDNWcX-Jum0jXKNQ9u-1Yfz__jlmqHfESbs7Pvk8vslQyIXOiUHlmKufaUPnctAX2PPeGAn1licOgpRBBCSMmwQSycoJotVJe4qakFdwrnnMrXsFBt-j8G2DOCZTnqrLITWkLYTw3lSZ4G-m8Dn4En7bj17iEJ05lLe6aGNcWulktGxpsvMlHcDwQLzcwGv8mO9oyokmy1Dd_OD-CD0MzSgENpen8Yk00VGxUof4ZwesN34b_5CXFDgt8W-1wdCAghO3dlu72R0Tajlg79M2PW97f69Z-99_-v_vv4DFRxvRBeQQHq19r_x5NmpUdx3k7hsO6nl3P8Hp6dvX1Gz6dltNxdBP8Bmcq_DI
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJuFAkZqL0hRE9uJnQNC4VG2tNsLrbS3YDu2qFRlF7IrxJ_iNzKTTUKXRdx6jDx2LM94ZuwZfwOwW-mY-2Bk5FPrIqmzENnEysgZtEeZToMO9HZ4cpKNz-SnaTrdgl_9WxhKq-x1Yquoq5mjO_J9gtEkaJgkfjP_FlHVKIqu9iU0VmJx5H_-wCNb8_rwPfJ3j_ODD6fvxlFXVSByIlU8MrlzVcg9N1VaOc-9oVhYlulEaSlEUMKIOJhAjkAQlVbKS_TbK5F4lfDEChz3GlxHwxvTYU9N1XCng-4PjpJ0zwBjofcXBImZpASQsG74NrzZzaTMvyKzrcE7uAO3O0-VFSvRugtbvr4HNyZdLP4-fC5sTQ7vBWuWlu7_KaGVtbaxe9vJZoF9LN4WBUO16ud4uifSJSqRhp3XrLmc78cs1ap4AGdXspgPYbue1f4xMOcE6o88tyg90qbC-MTkmuB0pPM6-BG86tevdB1-OZXRuCjbOLrQ5WJe0mLjBx_B7kA8X8F2_Jtsp2dE2e3dpvwjaSN4OTTjrqOlNLWfLYmGipsq1HcjeLTi2_AfnlGsMsXeao2jAwEheq-31OdfW2TvFtuHxtzreX9pWpvTf_L_6b-Am-PTyXF5fHhy9BRuUa82dVHuwPbi-9I_Q3dqYZ-3Mszgy1Vvmt8cqjNW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NTpp4QYy_hQ2MtL0gRa3tJHYe0JSxlY2xagIm7S2zHVtMmtJCWiG-Gp9uvtQJK0W87THy2bHuzuez7_w7gJ1SDpl1Ko5sok0Uy9RFmuo4MsrvR6lMnHT4dvh0nB6dxx8vkos1-N2-hcG0ytYmNoa6nBi8Ix8gjCZCw9DhwIW0iLOD0d70e4QVpDDS2pbTWKjIif310x_f6nfHB17Wu4yNDr--P4pChYHI8ESwSGXGlC6zTJVJaSyzCuNiaSqpkDHnTnDFh045dAocL6UQNvY-fMmpFZRRzf2492Bd4KmoB-v7h-Ozz90Nj3eG_Dg0PAoccjmYIUAmTRAuYXkbXPFtV1M0_4rTNtvf6CE8CH4ryReKtglrtnoEG6chMv8YvuS6Qvf3mtRzjdEATG8lzU4ZXnqSiSMf8v08J97I2qk_6yPp3JuUmlxVpL6d_Uc0Vq54Aud3ws6n0KsmlX0OxBjurUmWaa9LsU64slRlEsF1YmOls3142_KvMAHNHItqXBdNVJ3LYjYtkNn-g_VhpyOeLkA8_k221QqiCCu5Lv7oXR_edM1-DSIrVWUnc6TBUqfCW78-PFvIrfsPSzFymfjeYkmiHQHiey-3VFffGpzvBukHx9xtZX9rWqvTf_H_6b-GDb9gik_H45OXcB87NXmM8Rb0Zj_mdtv7VjP9Kigxgcu7Xjc3j3A48Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abnormal+subcellular+localization+of+GABAA+receptor+subunits+in+schizophrenia+brain&rft.jtitle=Translational+psychiatry&rft.au=Mueller%2C+T+M&rft.au=Remedies%2C+C+E&rft.au=Haroutunian%2C+V&rft.au=Meador-Woodruff%2C+J+H&rft.date=2015-08-04&rft.issn=2158-3188&rft.eissn=2158-3188&rft.volume=5&rft.spage=e612&rft_id=info:doi/10.1038%2Ftp.2015.102&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon